학술논문
Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth
Document Type
Article
Author
Keller, M.; Rohlf, K.; Glotzbach, A.; Leonhardt, G.; Lüke, S.; Derksen, K.; Demirci, Ö.; Göçener, D.; Overbeck, N.; Reinders, J.; Cadenas, C.; Hengstler, J.G.; Edlund, K.; Marchan, R.; AlWahsh, M.; Lambert, J.; Lindskog, C.; Schmidt, M.; Brenner, W.; Baumann, M.; Zent, E.; Zischinsky, M.-L.; Hellwig, B.; Madjar, K.; Rahnenführer, J.
Source
In: Journal of Experimental and Clinical Cancer Research . (Journal of Experimental and Clinical Cancer Research, December 2023, 42(1))
Subject
Language
English
ISSN
17569966